National Center for Advancing Translational Sciences
E16877
The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
All labels observed (4)
| Label | Occurrences |
|---|---|
| National Center for Advancing Translational Sciences canonical | 15 |
| NCATS | 3 |
| NCATS Chemical Genomics Center | 1 |
| National Center for Advancing Translational Sciences programs | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T77701 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: National Center for Advancing Translational Sciences Context triple: [National Institutes of Health, hasPart, National Center for Advancing Translational Sciences]
-
A.
National Institute of General Medical Sciences
The National Institute of General Medical Sciences is a U.S. government biomedical research institute that supports fundamental, non-disease-specific science and training to advance understanding of biological processes and lay the groundwork for medical advances.
-
B.
National Institutes of Health
The National Institutes of Health is the United States’ primary federal biomedical research agency, supporting and conducting medical research to improve public health.
-
C.
Center for Scientific Review
The Center for Scientific Review is the National Institutes of Health component responsible for overseeing the peer review of most grant applications to ensure scientific merit and integrity in funding decisions.
-
D.
National Human Genome Research Institute
The National Human Genome Research Institute is a U.S. government biomedical research organization that leads and funds research on the structure, function, and impact of the human genome.
-
E.
National Institute of Child Health and Human Development
The National Institute of Child Health and Human Development is a U.S. federal biomedical research institute that focuses on understanding human development, improving reproductive health, and enhancing the lives of children and families.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: National Center for Advancing Translational Sciences Target entity description: The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
-
A.
National Institute of General Medical Sciences
The National Institute of General Medical Sciences is a U.S. government biomedical research institute that supports fundamental, non-disease-specific science and training to advance understanding of biological processes and lay the groundwork for medical advances.
-
B.
National Institutes of Health
The National Institutes of Health is the United States’ primary federal biomedical research agency, supporting and conducting medical research to improve public health.
-
C.
Center for Scientific Review
The Center for Scientific Review is the National Institutes of Health component responsible for overseeing the peer review of most grant applications to ensure scientific merit and integrity in funding decisions.
-
D.
National Human Genome Research Institute
The National Human Genome Research Institute is a U.S. government biomedical research organization that leads and funds research on the structure, function, and impact of the human genome.
-
E.
National Institute of Child Health and Human Development
The National Institute of Child Health and Human Development is a U.S. federal biomedical research institute that focuses on understanding human development, improving reproductive health, and enhancing the lives of children and families.
- F. None of above. chosen
Statements (48)
| Predicate | Object |
|---|---|
| instanceOf |
U.S. federal research agency
ⓘ
biomedical research center ⓘ institute of the National Institutes of Health ⓘ |
| abbreviation |
National Center for Advancing Translational Sciences
self-linksurface differs
ⓘ
surface form:
NCATS
|
| country |
United States of America
ⓘ
surface form:
United States
|
| employerOf | translational science researchers ⓘ |
| field |
biomedical research
ⓘ
clinical research ⓘ drug development ⓘ rare diseases research ⓘ translational science ⓘ |
| focus |
accelerating the development of new cures
ⓘ
accelerating the development of new diagnostics ⓘ accelerating the development of new treatments ⓘ improving the translational science process ⓘ |
| foundedBy | National Institutes of Health ⓘ |
| fundingSource | U.S. federal budget ⓘ |
| goal |
reduce the cost of developing new medical products
ⓘ
reduce the failure rate of new diagnostics and therapeutics ⓘ reduce the time it takes for laboratory discoveries to become treatments for patients ⓘ |
| hasPart |
Cures Acceleration Network
ⓘ
Division of Clinical Innovation ⓘ Division of Pre-Clinical Innovation ⓘ Office of Rare Diseases Research ⓘ |
| headquartersLocation | Bethesda, Maryland ⓘ |
| inception | 2011 ⓘ |
| jurisdiction |
United States government
ⓘ
surface form:
federal government of the United States
|
| language | English ⓘ |
| location |
Bethesda, Maryland
ⓘ
Maryland ⓘ United States of America ⓘ
surface form:
United States
|
| mission | to transform the translational science process so that new treatments and cures for disease can be delivered to patients faster ⓘ |
| operates |
Bridging Interventional Development Gaps program
ⓘ
Clinical and Translational Science Awards Program ⓘ National Center for Advancing Translational Sciences self-linksurface differs ⓘ
surface form:
NCATS Chemical Genomics Center
Office of Rare Diseases Research ⓘ
surface form:
Rare Diseases Clinical Research Network
Small Business Innovation Research program ⓘ Small Business Technology Transfer program ⓘ Therapeutics for Rare and Neglected Diseases program ⓘ Toxicology in the 21st Century program ⓘ |
| parentOrganization |
United States Department of Health and Human Services
ⓘ
surface form:
U.S. Department of Health and Human Services
|
| partOf | National Institutes of Health ⓘ |
| researchFocus |
biomarker development
ⓘ
drug repurposing ⓘ improving clinical trial efficiency ⓘ methods and technologies that cut across diseases and conditions ⓘ patient engagement in research ⓘ |
| website | https://ncats.nih.gov ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: National Center for Advancing Translational Sciences Description of subject: The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
Referenced by (20)
Full triples — surface form annotated when it differs from this entity's canonical label.